The Supreme Court Is Paying Attention To Patent Law Again

Law360, New York (April 1, 2013, 11:54 AM EDT) -- The U.S. Supreme Court’s decision in Mayo v. Prometheus surprised many patent practitioners with both its reasoning and its expected impact in a fast developing industry. Yet, a close look at Justice Stephen Breyer’s dissent from the denial of certiorari in Lab. Corp. in 2006 renders that surprise curious. Indeed, Justice Breyer had put the legal field on notice that the Supreme Court was paying attention to patent eligibility well before seemingly eliminating medical diagnostic patents with Prometheus. With Myriad V to be heard this term,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.